{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T02:20:44Z","timestamp":1773714044188,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T00:00:00Z","timestamp":1549929600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"United Kingdom\u2019s Department for International Development"},{"name":"Ministry of Health and Child Care, Zimbabwe"},{"name":"World Health Organisation"}],"content-domain":{"domain":["ijidonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ijid.2019.02.007","type":"journal-article","created":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T11:52:33Z","timestamp":1550231553000},"page":"236-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain  Line Probe Assay in Southern provinces, Zimbabwe"],"prefix":"10.1016","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0997-9799","authenticated-orcid":false,"given":"Collins","family":"Timire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Sandy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay M.V.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mkhokheli","family":"Ngwenya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Murwira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2980-7735","authenticated-orcid":false,"given":"Kudakwashe C.","family":"Takarinda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony D.","family":"Harries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijid.2019.02.007_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001300","article-title":"Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 Patients","volume":"9","author":"Ahuja","year":"2012","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.ijid.2019.02.007_bib0010","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.5588\/ijtld.15.0864","article-title":"Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis","volume":"20","author":"Bollela","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.ijid.2019.02.007_bib0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5588\/pha.16.0005","article-title":"Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert \u00ae MTB\/RIF in Zimbabwe","volume":"6","author":"Charambira","year":"2016","journal-title":"Public Health Action"},{"key":"10.1016\/j.ijid.2019.02.007_bib0020","article-title":"Resistance to second-line antituberculosis drugs and delay in drug susceptibility testing among multidrug-resistant tuberculosis patients in Shanghai","volume":"2016","author":"Chen","year":"2016","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ijid.2019.02.007_bib0025","series-title":"Zimbabwe Population-based HIV Impact Assessment (ZIMPHIA) 2015-2016","author":"Columbia University","year":"2016"},{"key":"10.1016\/j.ijid.2019.02.007_bib0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijid.2016.10.011","article-title":"Tuberculosis stigma as a social determinant of health: a systematic mapping review of research in low incidence countries","volume":"56","author":"Craiga","year":"2017","journal-title":"International Society for Infectious Diseases"},{"issue":"11","key":"10.1016\/j.ijid.2019.02.007_bib0035","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1093\/cid\/cix128","article-title":"Implications of failure to routinely diagnose resistance to second-line drugs in patients with rifampicin-resistant tuberculosis on Xpert MTB\/RIF: a multisite observational study","volume":"64","author":"Jacobson","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.ijid.2019.02.007_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.22605\/RRH4158","article-title":"Delay in initiation of treatment after diagnosis of pulmonary tuberculosis in primary health care setting: eight year cohort analysis from district Faridabad, Haryana, North India","volume":"17","author":"Kant","year":"2017","journal-title":"Rural Remote Health"},{"key":"10.1016\/j.ijid.2019.02.007_bib0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijid.2016.12.010","article-title":"Second line drug susceptibility testing to inform the treatment of rifampin-resistant tuberculosis: a quantitative perspective","volume":"56","author":"Kendall","year":"2017","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2019.02.007_bib0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5588\/pha.12.0103","article-title":"Are sputum samples of retreatment tuberculosis reaching the reference laboratories? A 9-year audit in Tanzania","volume":"I","author":"Kilale","year":"2013","journal-title":"Public Health Action"},{"issue":"3","key":"10.1016\/j.ijid.2019.02.007_bib0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5588\/ijtld.12.0797","article-title":"Systematic screening for active tuberculosis: rationale, definitions and key considerations","volume":"17","author":"L\u00f6nnroth","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"10.1016\/j.ijid.2019.02.007_bib0060","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2471\/BLT.13.124800","article-title":"Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis","volume":"92","author":"MacPherson","year":"2014","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.ijid.2019.02.007_bib0065","series-title":"Zimbabwe tuberculosis management guidelines","author":"Ministry of Health and Child Care","year":"2016"},{"key":"10.1016\/j.ijid.2019.02.007_bib0070","series-title":"National Tuberculosis Drug Resistance Survey for Zimbabwe","author":"Ministry of Health and Child Care","year":"2017"},{"key":"10.1016\/j.ijid.2019.02.007_bib0075","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijid.2018.07.012","article-title":"Bacteriologically confirmed pulmonary tuberculosis patients: loss to follow-up, death and delay before treatment initiation in Bulawayo, Zimbabwe from 2012\u20132016","volume":"76","author":"Mugauri","year":"2018","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2019.02.007_bib0080","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijid.2018.10.013","article-title":"Where, when and how many tuberculosis patients are lost from presumption until treatment initiation? A step by step assessment in a rural district in Zimbabwe","volume":"78","author":"Murongazvombo","year":"2018","journal-title":"Int J Infect Dis"},{"issue":"October","key":"10.1016\/j.ijid.2019.02.007_bib0085","first-page":"1","article-title":"Impact of rapid molecular diagnostic tests on time to treatment initiation and outcomes in patients with multidrug-resistant tuberculosis, Tamil, Nadu, India","volume":"2016","author":"Nair","year":"2016","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.ijid.2019.02.007_bib0090","series-title":"South African Tuberculosis Drug Resistance Survey 2012-14","author":"National Institute for Communicable Diseases","year":"2014"},{"key":"10.1016\/j.ijid.2019.02.007_bib0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/ijmy.ijmy_34_17","article-title":"Phenotypic low-level isoniazid resistance as a marker to predict ethionamide resistance in Mycobacterium tuberculosis","volume":"6","author":"Qamar","year":"2017","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.ijid.2019.02.007_bib0100","first-page":"137","article-title":"Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China. Int J Tuberc Lung Dis 2011; 15: 137\u2013139","volume":"15","author":"Qi","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2019.02.007_bib0105","series-title":"MGIT Procedure Manual or BACTECTM MGIT 960TM TB system","author":"Salman","year":"2006"},{"issue":"2","key":"10.1016\/j.ijid.2019.02.007_bib0110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5588\/pha.14.0098","article-title":"MDR-TB screening in a setting with molecular diagnostic techniques: Who got tested, who didn\u2019t and why?","volume":"5","author":"Shewade","year":"2015","journal-title":"Public Health Action"},{"issue":"4","key":"10.1016\/j.ijid.2019.02.007_bib0115","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jegh.2017.07.001","article-title":"Low pre-diagnosis attrition but high pre-treatment attrition among patients with MDR-TB: an operational research from Chennai, India","volume":"7","author":"Shewade","year":"2017","journal-title":"J Epidemiol Glob Health"},{"issue":"2","key":"10.1016\/j.ijid.2019.02.007_bib0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.5588\/pha.18.0003","article-title":"Delay and attrition before treatment initiation among MDR-TB patients in five districts of Gujarat, India","volume":"8","author":"Shewade","year":"2018","journal-title":"Public Health Action"},{"key":"10.1016\/j.ijid.2019.02.007_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102989","article-title":"Impact of introducing the line probe assay on time to treatment initiation of MDR-TB in Delhi, India","volume":"9","author":"Singla","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2019.02.007_bib0130","series-title":"Mycobacteriology Laboratory Manual","author":"Stop TB Partnership","year":"2014"},{"key":"10.1016\/j.ijid.2019.02.007_bib0135","series-title":"The paradigm shift 2016-2020: Global plan to End TB","author":"STOP TB Partnership","year":"2015"},{"issue":"6","key":"10.1016\/j.ijid.2019.02.007_bib0140","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/trstmh\/try054","article-title":"How has the Zimbabwe mycobacterial culture and drug sensitivity testing system among re-treatment tuberculosis patients functioned during the scale-up of the Xpert MTB\/RIF assay?","volume":"112","author":"Timire","year":"2018","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.ijid.2019.02.007_bib0145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5588\/pha.17.0117","article-title":"Has TB CARE1 sputum transport improved access to culture services for retreatment tuberculosis patients in Zimbabwe?","volume":"8","author":"Timire","year":"2018","journal-title":"Public Health Action"},{"issue":"5","key":"10.1016\/j.ijid.2019.02.007_bib0150","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/QAI.0000000000001526","article-title":"Impact of SMS\/GPRS printers in reducing time to early infant diagnosis compared with routine result reporting: a systematic review and meta-analysis","volume":"76","author":"Vojnov","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ijid.2019.02.007_bib0155","series-title":"Global TB Report 2016","author":"World Health Organisation","year":"2016"},{"key":"10.1016\/j.ijid.2019.02.007_bib0160","series-title":"Global Tuberculosis Report 2017","author":"World Health Organisation","year":"2017"},{"issue":"11","key":"10.1016\/j.ijid.2019.02.007_bib0165","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1056\/NEJMoa1614915","article-title":"Evaluation of a rapid molecular drug-susceptibility test for tuberculosis","volume":"377","author":"Xie","year":"2017","journal-title":"N Engl J Med"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219300712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971219300712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T06:19:14Z","timestamp":1561097954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971219300712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":33,"alternative-id":["S1201971219300712"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2019.02.007","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Access to second-line drug susceptibility testing results among patients with Rifampicin resistant tuberculosis after introduction of the Hain\u00ae Line Probe Assay in Southern provinces, Zimbabwe","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2019.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}